The COVID-19 pandemic has turned out to be a huge challenge and a burden for medical services struggling with a huge number of patients and their ailments [
- Dzieciatkowski T.
- Szarpak L.
- Filipiak K.J.
- Jaguszewski M.
- Ladny J.R.
- Smereka J.
COVID-19 challenge for modern medicine.
]. Currently in addition to the ever-growing number of COVID-19 cases related to the next wave, our attention should also be paid to patients who will struggle with a number of POST-COVID-19 complications. The implications of COVID-19 infection are continually being studied, both in terms of the frequency with which they occur and the mechanism by which they occur. People with LONG-COVID-19 and POST-COVID-19 syndromes may be unable to do activities as well as employment. COVID-19, on the other hand, may raise the risk of chronic illness. In the context of the emergency department, we should pay particular attention to the possible increase in the percentage of patients due to pancreatic disorders. The SARS-CoV-2 virus can assault the pancreas and induce pancreatic injury and acute pancreatitis, according to research. The mechanism behind it is yet unknown. In recent years, hypertriglyceridemia has become one of the primary causes of acute pancreatitis, and hyperlipidemia is common in COVID-19 patients. COVID-19 individuals had a high rate of hyperlipidemia, with a total incidence of 32.98%. Hyperlipidemia may have a role in the development of acute pancreatitis in COVID-19 and POST-COVID-19 patients [
- Tang Q.
- Gao L.
- Tong Z.
- Li W.
Hyperlipidemia, COVID-19 and acute pancreatitis: a tale of three entities [published online ahead of print, 2022 Apr 2].
]. In addition, although we already know about the adverse impact of diabetes on the course of COVID-19, newer and newer reports about it are appearing [
- Kaminska H.
- Szarpak L.
- Kosior D.
- Wieczorek W.
- Szarpak A.
- Al-Jeabory M.
- et al.
Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review andmeta-analysis.
]. Researchers discovered reduced granularity in beta-cell insulin production after infection with COVID-19, as well as decreased glucose-stimulated secretion. Even though they had no prior history of diabetes, some COVID-19 individuals acquired insulin resistance and raised blood glucose levels. The immune system can stay active for months after a COVID-19 infection, lowering the efficacy of insulin in the liver, muscles, and fat cells. In a large cohort study, the population following COVID-19 was compared to acute upper respiratory infections (AURI). Age, gender, health insurance, COVID-19 / AURI index month, and comorbidities including obesity, hypertension, hyperlipidemia, myocardial infarction, and stroke were used to match patients. COVID-19 infected individuals had a greater risk of type 2 diabetes than AURI infected people. COVID-19 patients acquired diabetes at a rate of 15.8 per 1000 individuals per year, compared to 12.3 for AURI patients. The adjusted IRR for type 2 diabetes was 1.28 when marginal models were used. Overall, the COVID-19 group had a 28% higher relative risk of acquiring diabetes than the AURI group [
- Rathmann W.
- Kuss O.
- Kostev K.
Incidence of newly diagnosed diabetes after COVID-19.
]. Due to the induction of diabetes and acute pancreatitis in the POST-COVID-19 condition, the pancreas should definitely be a focus of our attention. Patients with new undiagnosed diabetes, as well as acute pancreatitis that is most likely connected to cholesterol levels, should be given extra care. Studies have shown that persons with high levels of high-density lipoproteins in their blood are less prone to severe COVID-19 infection, which is another important factor to consider among COVID-19 patients [
Chidambaram, Vignesh Kumar, Amudha Majella, Marie Gilbert Seth, Bhavna Sivakumar, Ranjith Kumar Voruganti, Dinesh Bavineni, Mahesh Baghal, Ahmad Gates, Kim Kumari, Annu Al'Aref, Subhi J. Galiatsatos, Panagis Karakousis, Petros Mehta, JL, Higher HDL Cholesterol Levels Decrease Susceptibility to COVID-19 Infection. doi:https://doi.org/10.2139/ssrn.4074563. Available at SSRN: https://ssrn.com/abstract=4074563
]. During our work, we must be ready for the increased number of patients suffering from previously undiagnosed diabetes acquired as the POST-COVID-19 syndrome, as well as those who, due to the pandemic, were unable to obtain this diagnosis, which may overlap. COVID-19 itself affects the lipid metabolism, but additionally the overlapping mode of isolation that took place may mean that we will have to deal with a significantly increased percentage of patients with acute pancreatitis. More research is needed to explain the effects of COVID-19 and the LONG-COVID-19 syndrome on the pancreas.
Publication stageIn Press Journal Pre-Proof
© 2022 Published by Elsevier Inc.